Age-dependent effects of protein restriction on dopamine release

FUNDING AND DISCLOSURE This work was supported by the Biotechnology and Biological Sciences Research Council [grant # BB/M007391/1 to J.E.M.], the European Commission [grant # GA 631404 to J.E.M.], The Leverhulme Trust [grant # RPG-2017-417 to J.E.M.] and the Tromsø Research Foundation [grant # 19-S...

Full description

Bibliographic Details
Published in:Neuropsychopharmacology
Main Authors: Naneix, Fabien, Peters, Kate Z., Young, Andrew M. J., McCutcheon, James E.
Other Authors: University of Aberdeen.Aberdeen Cardiovascular and Diabetes Centre, University of Aberdeen.Rowett Institute
Format: Article in Journal/Newspaper
Language:English
Published: 2021
Subjects:
R1
Online Access:https://hdl.handle.net/2164/16482
https://doi.org/10.1038/s41386-020-0783-z
http://www.scopus.com/inward/record.url?scp=85088831480&partnerID=8YFLogxK
Description
Summary:FUNDING AND DISCLOSURE This work was supported by the Biotechnology and Biological Sciences Research Council [grant # BB/M007391/1 to J.E.M.], the European Commission [grant # GA 631404 to J.E.M.], The Leverhulme Trust [grant # RPG-2017-417 to J.E.M.] and the Tromsø Research Foundation [grant # 19-SG-JMcC to J. E. M.). The authors declare no conflict of interest. ACKNOWLEDGEMENTS The authors would like to acknowledge the help and support from the staff of the Division of Biomedical Services, Preclinical Research Facility, University of Leicester, for technical support and the care of experimental animals. Peer reviewed